A modified factor VIIa is provided. The modified factor has increased
amidolytic activity in the absence of T.F. and a higher affinity for T.F.
when compared to the native factor VIIa but does not have substantially
altered proteolytic activity when bound to T.F. Nucleic acid molecules
that encode the factor, expression vectors that contain the nucleic acid
molecules, cells that contain the nucleic acid molecules, and cells
transformed with the expression vector are also provided. In a preferred
embodiment, the modified factor is a human factor VIIa.